Wednesday, August 31, 2022

FDA MedWatch - CereLink ICP Monitor by Integra

Class I Recall - Due to Risk of Incorrect Intracranial Pressure Readings

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment